2-Year U.S. Treasury Note Continuous Contract $103.457-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $107.688 0.031 0.03% 10-Year U.S. Treasury Note Continuous Contract $110.656 0.078 ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has reported a recent sale of shares by Chief Financial Officer Secora Michael. According to the latest filing, the CFO ...

The NASDAQ refers to the National Association of Securities Dealers Automated Quotations exchange. It was the world’s first all-electronic stock exchange and is subject to the regulatory ...

Company to host public (L)earnings call on February 28th at 8:30 am ET / 6:30 am MT / 1:30 pm GMT Salt Lake City, UT, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX),... ByInvesting.com ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Market-cap weighting is sensible, but a Nasdaq-only mandate is not. The fund excludes financials firms and all stocks that trade on rival exchanges. The Nasdaq-100 is heavy on tech stocks yet ...

Fidelity Nasdaq Composite Index Fund earns an Above Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day.

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...